HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

HIV prevention | Image credit: magann - stock.adobe.com
CDC Updates Guidelines for Use of Nonoccupational PEP

May 8th 2025

These guidelines act as an update to the 2016 guidelines for the use of nonoccupational postexposure prophylaxis (PEP) after exposure to HIV.

Woman with HIV awareness ribbon | Image credit: Krakenimages.com - stock.adobe.com
Women With 90% ART Adherence More Likely to Report Viral Suppression

May 6th 2025

Illicit drugs | Image credit: Stanislau_V - stock.adobe.com
SDOH Domains at Risk Correlated With Substance Use in People With HIV

May 2nd 2025

HIV | Image credit: reddish - stock.adobe.com
Family Dynamics, Mental Health Influence Adherence to ART

April 29th 2025

Richard Hughes IV, JD, MPH
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

April 21st 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
May 9th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

The EMERALD and AMBER Trials in HIV
December 27th 2017

The EMERALD and AMBER Trials in HIV

Selecting a Therapeutic Regimen for HIV Treatment
December 27th 2017

Selecting a Therapeutic Regimen for HIV Treatment

Considerations for Prescribing Therapy for HIV
December 27th 2017

Considerations for Prescribing Therapy for HIV

A Current Look at Managing HIV
December 27th 2017

A Current Look at Managing HIV

Determining Cost-Effectiveness of Newer HIV Therapies
December 27th 2017

Determining Cost-Effectiveness of Newer HIV Therapies

Emerging Therapies in HIV
December 27th 2017

Emerging Therapies in HIV

Collaborative Approach in Managing HIV Treatment Costs
December 27th 2017

Collaborative Approach in Managing HIV Treatment Costs

HIV Therapy Utilization Management Concerns
December 27th 2017

HIV Therapy Utilization Management Concerns

Formulary Decision-Making Challenges in HIV
December 27th 2017

Formulary Decision-Making Challenges in HIV

Balancing Cost and Physician Choice in HIV
December 27th 2017

Balancing Cost and Physician Choice in HIV

HIV Medication Adherence and Resistance Development
December 27th 2017

HIV Medication Adherence and Resistance Development

Nuances of HIV Treatment
December 27th 2017

Nuances of HIV Treatment

HIV Treatment Initiation and Resistance Testing
December 27th 2017

HIV Treatment Initiation and Resistance Testing

Population Management and Cost Containment in HIV
December 27th 2017

Population Management and Cost Containment in HIV

Impact of HIV Guideline Changes on Payer Decisions
December 27th 2017

Impact of HIV Guideline Changes on Payer Decisions

HIV Guideline Update
December 27th 2017

HIV Guideline Update

Goals of Therapy in HIV Infection
December 27th 2017

Goals of Therapy in HIV Infection

Today's HIV Treatment Challenges
December 27th 2017

Today's HIV Treatment Challenges

HIV: Achieving Normal Life Expectancy
December 27th 2017

HIV: Achieving Normal Life Expectancy

Special Considerations in HIV Management
December 27th 2017

Special Considerations in HIV Management

The Past, Present, and Future of HIV Funding
December 11th 2017

The Past, Present, and Future of HIV Funding

Jaime Rosenberg
A Kaiser Family Foundation web briefing navigated the HIV/AIDS funding landscape, taking a look at trends over time, the latest data, and what we might expect in the future.
NCI Expands Clinical Trial Access for Patients With HIV in CITN-12 Trial
December 5th 2017

NCI Expands Clinical Trial Access for Patients With HIV in CITN-12 Trial

Jaime Rosenberg
The National Cancer Institute (NCI) is sponsoring an ongoing clinical trial that evaluates pembrolizumab in people with HIV who have relapsed or refractory cancer and are also taking antiretroviral therapy. People with HIV are often excluded from participating in clinical trials of new cancer treatments because of concerns that treatments may be unsafe for them.
What We're Reading: Uterine Transplant Birth; Opioid Treatment; Curbing HIV
December 4th 2017

What We're Reading: Uterine Transplant Birth; Opioid Treatment; Curbing HIV

AJMC Staff
A woman gives birth after receivng a uterine transplant for the first time in the US; a once-monthly treatment for patients with poioid addiction gains FDA approval; and LA public health officials launch an initiative to reduce the annual number HIV infections.
Scientists Find Brake for Protein Shell of HIV, Blocking Infection
December 3rd 2017

Scientists Find Brake for Protein Shell of HIV, Blocking Infection

Allison Inserro
Researchers find brake mechanism that prevents an essential shell from forming on virus that causes AIDS.
On World AIDS Day, Highlighting Prevention Efforts Through Report on Voluntary Medical Male Circumcision
December 2nd 2017

On World AIDS Day, Highlighting Prevention Efforts Through Report on Voluntary Medical Male Circumcision

Jaime Rosenberg
Countries in Southern and Eastern Africa have the highest prevalence of HIV worldwide. The Joint United Nations Program on HIV/AIDS strategy to end AIDS by 2030 has been dedicated to preventing HIV through voluntary medical male circumcision in Southern and Eastern African countries with HIV epidemics and low male circumcision prevalence.
Site Logo
September 18th 2017

HIV Medicine Association Releases Guidelines for Chronic Pain Management

Alison Rodriguez
The HIV Medicine Association of the Infectious Disease Society of America recently published clinical practice guidelines for managing chronic pain in patients with HIV.
Site Logo
August 25th 2017

What We're Reading: HIV Privacy Breach; Googling Depression; All ACA Counties Covered

AJMC Staff
Site Logo
July 25th 2017

What We're Reading: Monthly HIV Shot; Molina Layoffs; Charlie Gard Treatment

AJMC Staff
Site Logo
June 7th 2017

Expert Panel: Access to Multiple Treatment Options Is Needed to Continue the Fight Against HIV

Jerry Cade, MD Jeff Dunn, PharmD, MBA Holly Kilness-Packett, MA Glen Pietrandoni, RPh, AAHIVP Carl Schmid, MBA
A multidisciplinary panel of HIV experts gathered in October 2016 to discuss the current state of HIV care and develop critical recommendations for Pharmacy and Therapeutics (P&T) committee members to consider when developing policies affecting their member populations who are living with HIV. This paper presents the panel’s discussion, consensus opinion, and conclusions.
Site Logo
June 5th 2017

On Anniversary of First Report, a Change to HIV.gov

Mary Caffrey
The change reflects scientific advances that have converted AIDS from a certain death sentence to a condition that can be managed with proper diagnosis and treatment.
<1
...
242526272829303132>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo